4-butyrolactone has been researched along with Diabetes Mellitus in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, S; Wang, G; Yang, Z | 1 |
| Tsujino, Y | 1 |
| Jones, PJ; Marinangeli, CP | 1 |
| Brown, A; Bycroft, BW; Chhabra, SR; Pritchard, DI; Todd, I; Williams, P; Wood, P | 1 |
| Bonnet, F; Gilbert, R | 1 |
1 trial(s) available for 4-butyrolactone and Diabetes Mellitus
| Article | Year |
|---|---|
Whole and fractionated yellow pea flours reduce fasting insulin and insulin resistance in hypercholesterolaemic and overweight human subjects.
Topics: 4-Butyrolactone; Adiposity; Adult; Body Composition; Cardiovascular Diseases; Cross-Over Studies; Diabetes Mellitus; Fasting; Female; Flour; Humans; Hypercholesterolemia; Insulin; Insulin Resistance; Lignans; Male; Middle Aged; Overweight; Phytotherapy; Pisum sativum; Plant Preparations; Risk Factors; Seeds | 2011 |
4 other study(ies) available for 4-butyrolactone and Diabetes Mellitus
| Article | Year |
|---|---|
Ligustilide alleviates the insulin resistance, lipid accumulation, and pathological injury with elevated phosphorylated AMPK level in rats with diabetes mellitus.
Topics: 4-Butyrolactone; AMP-Activated Protein Kinase Kinases; Animals; Blood Glucose; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diet, High-Fat; Humans; Insulin; Insulin Resistance; Lipid Metabolism; Liver; NF-E2-Related Factor 2; Obesity; Phosphorylation; Protein Kinases; Rats | 2021 |
A New Agonist for Peroxisome Proliferation-activated Receptor γ (PPARγ), Fraglide-1 from Zhenjiang Fragrant Vinegar: Screening and Characterization Based on Cell Culture Experiments.
Topics: 4-Butyrolactone; Acetic Acid; Animals; Anti-Obesity Agents; Cells, Cultured; Chlorocebus aethiops; Chromans; Diabetes Mellitus; Dietary Supplements; Dose-Response Relationship, Drug; Insulin Resistance; Obesity; Oryza; Phytotherapy; PPAR gamma; Thiazolidinediones; Troglitazone; Uncoupling Protein 1 | 2017 |
Alleviation of insulitis and moderation of diabetes in NOD mice following treatment with a synthetic Pseudomonas aeruginosa signal molecule, N-(3-oxododecanoyl)-L-homoserine lactone.
Topics: 4-Butyrolactone; Adjuvants, Immunologic; Animals; Diabetes Mellitus; Dimethyl Sulfoxide; Disease Models, Animal; Homoserine; Inflammation; Islets of Langerhans; Mice; Mice, Inbred NOD; Pancreatic Diseases; Pseudomonas aeruginosa | 2005 |
Enterolactone and coronary events.
Topics: 4-Butyrolactone; Coronary Disease; Diabetes Mellitus; Estrogens; Humans; Lignans; Risk Assessment | 2000 |